AssetMark’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
AssetMark's ASND Position: Q3 2026 in Review
AssetMark increased its Ascendis Pharma A/S (ASND) stake by 23% in Q3 2026, buying an estimated $789K and bringing the position to 16,611 shares worth $3.78M. The position accounts for 0.01% of the portfolio, ranked #801.
AssetMark first reported a position in ASND in Q3 2024 and has held it in 9 quarters since. 252 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- AssetMark held 16,611 shares of Ascendis Pharma A/S worth $3.78M as of Q3 2026.
- AssetMark bought 3,116 Ascendis Pharma A/S shares in Q3 2026, an estimated $789K.
- Ascendis Pharma A/S made up 0.01% of AssetMark's portfolio in Q3 2026, its #801 holding.
- AssetMark first reported a position in Ascendis Pharma A/S in Q3 2024 and has held it in 9 quarters since.
- 252 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.